Long-Term Effects of Kawasaki Disease
The long-term sequelae of Kawasaki disease depend critically on whether coronary artery abnormalities developed during the acute phase, with children who had no coronary involvement returning to excellent health, while those with persistent aneurysms face ongoing risks of thrombosis, stenosis, myocardial infarction, and death. 1, 2
For Patients WITHOUT Coronary Artery Abnormalities (85-90% of treated cases)
Children without cardiac sequelae during the first month appear to return to their previous excellent state of health without signs or symptoms of cardiac impairment. 1 However, emerging evidence suggests potential subclinical effects:
- Endothelial dysfunction may persist even in patients without demonstrable coronary abnormalities 2
- Abnormal lipid profiles have been documented in some follow-up studies 2
- Arterial wall changes including reduced distensibility and increased thickness have been found in carotid arteries 6-20 years post-disease, suggesting potential predisposition to accelerated atherosclerosis 1
Critical caveat: The full impact on long-term myocardial function, late-onset valvular regurgitation, and coronary artery status in this population remains unknown and requires continued surveillance into adulthood 1.
For Patients WITH Coronary Artery Abnormalities (15-25% untreated, 5% with IVIG treatment)
Coronary Aneurysm Evolution
Angiographic resolution occurs in 50-67% of vessels with coronary aneurysms within 1-2 years, but this "regression" is misleading 1:
Factors favoring regression:
- Smaller initial aneurysm size (most important predictor)
- Age at onset <1 year
- Fusiform rather than saccular morphology
- Distal coronary segment location 1
Critical understanding: Even "regressed" aneurysms are NOT normal vessels. They show:
- Fibrous intimal thickening on pathology 1
- Marked myointimal proliferation on intravascular ultrasound 1
- Reduced vascular reactivity to isosorbide dinitrate 1
- Endothelial dysfunction with constriction to acetylcholine 1
Progressive Stenotic Disease
Stenotic lesions from myointimal proliferation are frequently progressive, with prevalence rising almost linearly over time. 1 The highest progression rate occurs in patients with large aneurysms, particularly giant aneurysms (≥8mm diameter) 1.
Major Adverse Cardiac Events
Myocardial infarction from thrombotic occlusion is the principal cause of death from Kawasaki disease. 1
Timing and risk stratification:
- Highest MI risk occurs in the first year after disease onset 1
- Most fatal attacks involve obstruction of the left main coronary artery OR both the right coronary artery and left anterior descending artery 1
- Giant aneurysms have the worst prognosis due to sluggish blood flow and frequent stenotic lesions at aneurysm entry/exit points 1
Long-term mortality data:
- Overall survival: 92-99% at 10 years, 85-99% at 20 years, 88-94% at 30 years 3
- Mortality significantly elevated in those with cardiac sequelae 4
- Ischemic heart disease develops in 4.7% and myocardial infarction in 1.9% during long-term follow-up 5
- Death rate of 0.8% in long-term cohorts 5
Valvular Complications
Mitral regurgitation occurs in approximately 1% of cases and may result from:
- Transient papillary muscle dysfunction
- Myocardial infarction
- Valvulitis (acute or late-onset) 1
Aortic regurgitation is less common:
- Documented in approximately 4-5% of patients 1
- Late-onset aortic regurgitation is exceedingly rare but may require valve replacement 1
Myocardial Abnormalities
Myocardial biopsy studies reveal persistent abnormalities including fibrosis, cellular disarrangement, abnormal myocyte branching, and hypertrophy at all time periods (2 months to 11 years post-onset), with severity unrelated to coronary artery abnormalities 1.
However, long-term myocardial contractility and function measured by echocardiography appear normal except in patients with ischemic heart disease. 1
Rare Complications
- Coronary aneurysm rupture can occur within the first few months but is exceedingly rare 1
- Systemic artery aneurysms develop in approximately 2.2% of patients 5
- Cardiac transplantation required in rare cases with severe irreversible myocardial dysfunction and unfeasible revascularization options 1
Non-Cardiac Long-Term Effects
Increased risk of allergic diseases has been demonstrated in all six studies examining this outcome 3. Seven of 10 studies reported increased risk of early atherosclerosis 3.
Management Implications
Serial stress tests and myocardial imaging are mandatory in patients with significant coronary artery disease to determine need for angiography and intervention 1. Risk stratification should guide frequency of follow-up, physical activity restrictions, and anticoagulation strategies 2, 1.
Patients with aneurysms require lifelong and uninterrupted cardiology follow-up 6, as the risk level may change over time due to evolving coronary artery morphology 1.